Resumen de Corporate governance quarterly: : Sotheby's poison pill.
The article discusses the court case on the dispute related to the efforts of hedge fund group Third Point to gain representation on the board of brokerage firm Sotheby's. A background on the stake ownership filing of Third Point with the U.S. Securities and Exchange Commission (SEC) and the rights plan adopted by Sotheby's is presented. The ruling of the Delaware Chancery Court to deny Third Point's claim to increase its holding in Sotheby's is discussed.
